| Stellaromics–Catalyst4: investment, 202502 financing round Series B totalling $80m incl lead investor Catalyst4 |
2025-02-11 |
| Stellaromics–Oak Street Communications: public relations, 202502 service existent Oak Street is media contact for Stellaromics |
2025-02-11 |
| Stellaromics–SEVERAL: investment, 202502 financing round Series B $80m led by Catalyst4 |
2025-02-11 |
| Stellaromics–Stanford Univ: investment, 202502 financing round Series B totalling $80m incl co-investor Stanford University Ventures |
2025-02-11 |
| Owlstone–Gates Foundation: grant, 202404– initial $1.5m grant to develop breat-based diagnostics for developing countries from Gates Foundation |
2025-01-15 |
| Agilent–JPMorgan Chase: investor conference, 202501 supply service Agilent presents at JP Morgan Healthcare Conference 2025 |
2025-01-14 |
| Mérieux–JPMorgan Chase: investor conference, 202501 supply service bioMérieux presents at JP Morgan Healthcare Conference 2025 |
2025-01-14 |
| Bruker–JPMorgan Chase: investor conference, 202501 supply service Bruker presents at JP Morgan Healthcare Conference 2025 |
2025-01-13 |
| miDiagnostics–Thermo Fisher: investment, 202412 financing round Series D totalling €30m incl lead investor Thermo Fisher Scientific |
2024-12-04 |
| Mainz Biomed–Thermo Fisher: colorectal cancer screening test, 202411– collab developm + commercialisation assays for mRNA-based CRC screening tests |
2024-11-12 |
| PrognomiQ–aMoon: investment, 202411 financing round Series D totalling $34m incl existing + co-investor aMoon |
2024-11-05 |
| PrognomiQ–Bruker: investment, 202411 financing round Series D totalling $34m incl existing + co-investor Bruker |
2024-11-05 |
| PrognomiQ–Catalio Capital: investment, 202411 financing round Series D totalling $34m incl existing + co-investor Catalio Capital Management |
2024-11-05 |
| PrognomiQ–Invus Group: investment, 202411 financing round Series D totalling $34m incl existing + co-investor Invus |
2024-11-05 |
| PrognomiQ–OTHER: investment, 202411 financing round Series D totalling $34m incl new large strategic diagnostics investor |
2024-11-05 |
| PrognomiQ–SEVERAL: investment, 202411 financing round Series D $34m led by Seer Inc |
2024-11-05 |
| Danaher–Ion Opticks: liquid chromatography, 202410– collab co-marketing of Aurora Series XS LC columns with ZenoTOF line MS systems of Sciex |
2024-10-25 |
| Bureau Veritas–Mérieux: investment, 202410– acquisition €360m of global food testing of Bureau Veritas by Mérieux NutriSciences |
2024-10-07 |
| Bruker–Morgan Stanley: investor conference, 202409 supply service Bruker presents at Morgan Stanley Global Healthcare Conference NY |
2024-09-06 |
| Bruker–Wells Fargo: investor conference, 202409 supply service Bruker presents at Wells Fargo Healthcare Conference in Boston |
2024-09-04 |
| Genedata–Danaher: investment, 202408 acquisition of Genedata that will join Danaher’s Life Science segment |
2024-08-19 |
| Standard BioTools–UBS: investor conference, 202408 supply service Standard BioTech participates in UBS Genomic Medicine Summit |
2024-08-14 |
| Allogene Therapeutics–Baird: investor conference, 202408 supply service Allogene participates in Baird 2024 Global Healthcare Conference |
2024-08-13 |
| Allogene Therapeutics–Canaccord Genuity: investor conference, 202408 supply service Allogene participates in Canaccord Genuity Growth Conference |
2024-08-13 |
| Standard BioTools–Canaccord Genuity: investor conference, 202408 supply service Standard BioTech participates in Canaccord Genuity Growth Conference |
2024-08-13 |
| Novalix–Bruker: investment, 202408 strategic minority investment €na by Bruker |
2024-08-07 |
| Thermo Fisher–Biomatter Designs: enzyme design, 202408 supply existent customer Thermo Fisher |
2024-08-05 |
| Agilent–Sigsense Technologies: lab management software, 202407 supply existent Sigsense technology available via Agilent CrossLab Connect |
2024-07-29 |
| Sigsense Technologies–Agilent: investment, 202407 acquisition €na of Sigsense by Agilent |
2024-07-29 |
| Biovectra–Agilent: investment, 202407– acquisition of Biovectra for $925m by Agilent from H.I.G. Capital |
2024-07-22 |
| CytoReason–Thermo Fisher: investment, 202407 financing round totalling $80m incl investor Thermo Fisher Scientific |
2024-07-17 |
| Sartorius–Nvidia: AI-based drug discovery + manufacturing, 202405– collab expansion incl adaption of Nvidia Clara Suite + DGX platform |
2024-05-16 |
| Owlstone–Gates Foundation: investment, 202501 financing round Series E first closing totalling $27m incl $5m from new + co-investor Gates Foundation |
2024-04-25 |
| NanoString–Bruker: investment, 202404– acquisition $392.6m of substantially all assets winning bid under Bankruptcy Code |
2024-04-17 |
| NanoString–Patient Square Capital: investment, 202403–202404 stalking horse bid $220m for assets under Bankruptcy Code NOT REALISED |
2024-03-10 |
| Waters–Plasmion: ionisation technology, 202402– collab co-marketing/promotion of SICRIT ion source with Waters Acquity QDa + Select Series Cycli IMS |
2024-02-21 |
| Enable Medicine–KKH Advisors: public relations, 202402 service existent by KKH Advisors |
2024-02-13 |
| Chemspeed–Bruker: investment, 202401– acquisition €na of Chemspeed Technology AG by Bruker |
2024-01-25 |
| Agilent–JPMorgan Chase: investor conference, 202401 supply service Agilent presents at JP Morgan Healthcare Conference 2024 |
2024-01-09 |
| Bruker–JPMorgan Chase: investor conference, 202401 supply service Bruker presents at JP Morgan Healthcare Conference 2024 |
2024-01-08 |
| Nion–Bruker: investment, 202401 acquisition $23m of Nion by Bruker |
2024-01-03 |
| LumiraDx–Roche: investment, 202312– acquisition $295m + $55m milestones of parts of LumiraDx Group related to innovative PoC technology |
2023-12-29 |
| Tome Biosciences–SEVERAL: investment, 202312 financing rounds Series A + B $213m announced at launch |
2023-12-12 |
| Olink–Thermo Fisher: investment, 202310– acquisition cash tender offer $3.1b at $26/share by Thermo Fisher |
2023-10-17 |
| SomaLogic–Standard BioTools: investment, 202310–202401 reverse merger with former SomaCare shareholders owning 57% of combined company |
2023-10-04 |
| Agilent–Exact Sciences: investment, 202309– acquisition €na of Resolution Bioscience by Exact Sciences from Agilent |
2023-09-12 |
| Abcam–Danaher: investment, 202308– acquisition $24/share in cash = enterprise value $5.7b incl assumed indebtedness + net of acquired cash |
2023-08-28 |
| PhenomeX–Bruker: investment, 202308–202310 acquisition cash tender offer $108m by Bruker at $1/share |
2023-08-17 |
| NuChem Sciences–Sygnature Discovery: investment, acquisition of NuChem Sciences by Sygnature Discovery |
2023-07-31 |
| Revvity–Scitara: lab informatics, 202307– collab expansion product integration of Signals Software Suite with DLX technology |
2023-07-27 |
| Tome Biosciences–Bruker: investment, 202312 financing rounds Series A + B totalling $213m incl $10m from investor Bruker Corp 7/23 |
2023-07-26 |
| Orange Science–Organomation: sample evaporators, 202307– distribution of nitrogen blowdown evaporator lines of Organimation in JP by Orange Science |
2023-07-20 |
| Interherence–Bruker: investment, 202307 acquisition $17.3m of Interherence GmbH by Bruker |
2023-07-03 |
| Lunaphore–Bio-Techne: investment, 202306–202307 acquisition $170.1m of Lunaphore by Bio-Techne |
2023-06-22 |
| Bruker–Leucadia: investor conference, 202306 supply service Brukers presents at Jefferies 2023 Healthcare Conference |
2023-06-09 |
| Sartorius–Waters: biopharma production technology, 202306– collab expansion integration of PATROL UPLC PAS with Resolute BioSMB platform |
2023-06-05 |
| Midwest Biosolutions–Bionter: analytical instruments, 202305– collab Midwest Bio to promote + sell Bionter products + services in the US |
2023-05-08 |
| Zontal–Bruker: investment, 202305 acquisition $14.8m of Zontal by Bruker |
2023-05-08 |
| Bio-Techne–Lunaphore: spatial omics, 202304– collab strategic partnership integrating COMET system with RNAscope technology |
2023-04-17 |
| Pinpoint Testing–Bruker: investment, 202303 acquisition $8.6m of Pinpoint Testing LLC by Bruker |
2023-03-28 |
| Agilent–Hamamatsu: digital pathology, 202303– collab distribution of NanoZoomer digital pathology slide scanners by Agilent |
2023-03-10 |
| Agilent–e-MSion: mass spectrometry technology, 2019– collab co-marketing of ExD cell technology with 6500 Series LC-/Q-TOF |
2023-03-09 |
| e-MSion–Agilent: investment, 202303 acquisition of e-MSion by Agilent |
2023-03-09 |
| Agilent–Proscia: digital pathology, 202303– collab ww distribution multi-year for Concentriq Dx platform with Agilent digital pathology solutions |
2023-03-08 |
| Fasmatech–Bruker: investment, 202303 acquisition $10.3m of Fasmatech by Bruker |
2023-03-03 |
| Biotage–KKR: investment, 202302– investment $25m tog with sale of Astrea Bioseparations by Gamma for shares resulting in 17% share in Biotage of Gamma |
2023-02-15 |
| Wyatt Technology–Waters: investment, 202302–202305 acquisition $1.36b in cash of Wyatt by Waters |
2023-02-15 |
| Danaher–Seed Biosciences: cell dispenser, 202302– distribution excl of DinspenCell in US + Asia + resale in Europe by Molecular Devices |
2023-02-07 |
| SAMDI Tech–Charles River: investment, 202301 acquisition of remaining 80% not already owned for $50m in cash by Charles River |
2023-01-30 |
| Agilent–Plasmion: ionisation technology, 202301– collab co-marketing of SICRIT ion source with Agilent Ultivo LC/TQ + LC/MSD iQ MS systems |
2023-01-18 |
| InDevR–Adjuvant Capital: investment, 202301 financing round Series B totalling $9m incl $4m from Adjuvant Capital |
2023-01-17 |
| InDevR–Mérieux: investment, 202301 financing round Series B totalling $9m incl $5m from bioMérieux in connection w partnership |
2023-01-17 |
| InDevR–SEVERAL: investment, 202301 financing round Series B $9m from bioMérieux + Adjuvant Capital |
2023-01-17 |
| Mérieux–InDevR: VaxArray platform, 202301– excl distribution of VaxArray portfolio by bioMérieux in Europe |
2023-01-17 |
| Akoya Biosciences–JPMorgan Chase: investor conference, 202301 supply service Akoya presents at JP Morgan Healthcare Conference 2023 |
2023-01-11 |
| Agilent–Goldman Sachs: investor conference, 202301 supply service Agilent presents at Goldman Sachs Healthcare CEOs Unscripted Conference 2023 |
2023-01-10 |
| Agilent–JPMorgan Chase: investor conference, 202301 supply service Agilent presents at JP Morgan Healthcare Conference 2023 |
2023-01-10 |
| Bruker–JPMorgan Chase: investor conference, 202301 supply service Bruker presents at JP Morgan Healthcare Conference 2023 |
2023-01-09 |
| Waters–JPMorgan Chase: investor conference, 202301 supply service Waters presents at JP Morgan Healthcare Conference 2023 |
2023-01-09 |
| Acquifer Imaging–Bruker: investment, 202301 acquisition $7.6m of Acquifer Imaging Gmbh + subsidiary Deltabyte GmbH by Bruker |
2023-01-05 |
| Danaher–Advanced Solutions: laboratory automation equipment, 202301 collab developm BAB400 with ImageXpress for 3D Cell Culture + sales by MolDev |
2023-01-04 |
| IsoPlexis–Berkeley Lights: investment, 202212–202303 merger acquisition $57.8m in shares with former Berkeley owners holding 75.2%, renamed PhenomeX |
2022-12-21 |
| Cellesce–Danaher: investment, 202212 acquisition of Cellesce by Molecular Devices |
2022-12-06 |
| Bruker–Leucadia: investor conference, 202211 supply service Bruker presents at Jefferies 2022 London Healthcare Conference |
2022-11-15 |
| Neurescence–Bruker: investment, 202211–202212 acquisition 100% of Neurescence Inc by Bruker |
2022-11-14 |
| Elemental Machines–SEVERAL: investment, 202211 financing round Series B $41m led by Sageview Capital |
2022-11-10 |
| Inscopix–Bruker: investment, 202211 acquisition $101.5m of Inscopix by Bruker |
2022-11-08 |
| Binding Site–Thermo Fisher: investment, 202210– acquisition £2.25b in cash from shareholder group led by Nordic Capital ANNOUNCED |
2022-10-31 |
| Agilent–Scitara: lab informatics, 202209– collab product integration of OpenLab CDS + SLIMS with Scientific Integration Platform SIP + DLX |
2022-09-21 |
| ValitaCell–Danaher: investment, 202209 acquisition of ValitaCell by Beckman Coulter Life Sciences |
2022-09-13 |
| Trace Analytics–908 Devices: investment, 202208 acquisition $15.3m upfront cash + $2m cash milestones |
2022-08-09 |
| Polymer Standards Service–Agilent: investment, 202208 acquisition €na of PSS by Agilent |
2022-08-02 |
| Namocell–Bio-Techne: investment, 202206–202207 acquisition $101.2m of Namocell by Bio-Techne |
2022-06-22 |
| Peptone–Bessemer Venture: investment, 202206 financing round Series A totalling $40m incl co-lead investor Bessemer Venture Partners |
2022-06-09 |
| Peptone–F-Prime: investment, 202206 financing round Series A totalling $40m incl co-lead investor F-Prime Capital |
2022-06-09 |
| Peptone–Nvidia: AI-based drug discovery, 202206 collab incl use of Nvidia DGX A100 supercomputer to run Peptone’s algorithmic engine |
2022-06-09 |
| Agilent–Mettler-Toledo: lab automation, –202206 collab developm + product integration automated + digitalised sample prep for LC/GC workflow |
2022-06-01 |
| PerkinElmer–Scitara: lab informatics, 202204– collab product integration of Signals informatics platform with Scientific Integration Platform SIP |
2022-04-14 |
| Refeyn–Northpond Ventures: investment, 202204 financing round Series B incl lead investor Northpond Ventures |
2022-04-11 |
| Enable Medicine–SEVERAL: investment, 202204 financing round Series A $60m led by Anthos Capital + General Catalyst |
2022-04-07 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
